Next-generation sequencing reveals novel mutations in a collision tumor of glioblastoma and meningioma

CNS Oncol. 2021 Jun 1;10(2):CNS70. doi: 10.2217/cns-2020-0029. Epub 2021 May 21.

Abstract

Primary intracranial collision tumors are rare in patients without predisposing factors. We report such a case in a 42-year-old female who presented with headaches and altered mental status. Imaging revealed a single heterogeneous, rim-enhancing lesion in the left parieto-occipital periventricular region, involving the corpus callosum. Stereotactic biopsy demonstrated glioblastoma. Subsequent tumor resection showed histologic evidence of glioblastoma and meningioma. Next-generation sequencing was performed on both tumor components. The glioblastoma exhibited a CDKN2A homozygous deletion and novel missense mutations in TAF1L and CSMD3, while no definitive genetic alterations were identified in the meningioma. Next-generation sequencing may yield insight into molecular drivers of intracranial collision tumors and aid in identifying future therapeutic targets.

Keywords: CSMD3; TAF1L; collision tumor; glioblastoma; meningioma; next-generation sequencing.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Neoplasms* / diagnostic imaging
  • Brain Neoplasms* / genetics
  • Female
  • Glioblastoma* / diagnostic imaging
  • Glioblastoma* / genetics
  • High-Throughput Nucleotide Sequencing
  • Homozygote
  • Humans
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningeal Neoplasms* / genetics
  • Meningioma* / diagnostic imaging
  • Meningioma* / genetics
  • Mutation / genetics
  • Sequence Deletion